1. Impact of Immune Response in Short-term and Long-term Outcomes After Minimally Invasive Surgery for Colorectal Liver Metastases: Results From a Randomized Study
- Author
-
Ricardo Robles Campos, Victor Lopez-Lopez, Pablo Pelegrin, Roberto Brusadin, Alvaro Gómez Ruiz, Valentín Cayuela, Ana García, Beatriz Abellán, and Asunción López-Conesa
- Subjects
Liver surgery ,medicine.medical_specialty ,business.industry ,Inflammatory response ,Liver Neoplasms ,Immunity ,Interleukin ,Gastroenterology ,law.invention ,Serum cytokine ,Immune system ,Randomized controlled trial ,law ,Internal medicine ,Invasive surgery ,medicine ,Long term outcomes ,Humans ,Laparoscopy ,Postoperative Period ,Colorectal Neoplasms ,business - Abstract
BACKGROUND The potential benefit related to laparoscopic liver surgery (LLS) for colorectal liver metastases outcomes is not well known. MATERIALS AND METHODS Serum cytokines associated with Th1 (tumor necrosis factor-α) and Th2 [interleukin (IL)-10 and IL-6] phenotypes were measured in 36 patients operated on for colorectal liver metastases by open liver surgery (OLS) and LLS. Measurements were performed at 3 time points: 1 day before surgery, day 3 postoperative, and 1 month postoperative. We compared the postoperative inflammatory response influence between LLS and OLS on long-term outcomes. RESULTS In both groups, only IL-6 levels on day 3 postoperative were higher than those measured preoperatively and at 1 month. Comparing the tumor necrosis factor-α levels between the LLS and OLS groups, preoperative (7.28 vs. 2.36), day 3 (7.99 vs. 4.08) and 1 month (7.39 vs. 1.99) postoperative levels were higher in the OLS group (P
- Published
- 2021
- Full Text
- View/download PDF